LifeScience Vaccines
Intended audience: General public Top 3 questions Why can’t I decide which vac...
May 25, 2021 | Opinion
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that G...
May 25, 2021 | News
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high...
May 24, 2021 | News
A study on CNPharm's antiviral oral formulation published in a special edition of Pharmaceuticals Hyundai Bioscience (KOSDAQ 048410) announced on ...
May 24, 2021 | News
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Unde...
May 24, 2021 | News
The company plans to produce 200 million doses of COVAXIN® per annum in the good manufacturing practice (GMP) facilities that are already operatio...
May 21, 2021 | News
As the rate of people receiving COVID-19 vaccinations has slowed, a new survey of physicians has revealed that doctors are working hard to combat vaccine h...
May 20, 2021 | Analysis
Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day). AptameX delivers sensitivity o...
May 20, 2021 | News
Pune-based Mylab Discovery Solutions Ltd has developed CoviSelfTM (PathoCatch) COVID-19 OTC Antigen LF device and an app is developed to guide individuals ...
May 20, 2021 | News
Lipid-polymer nanocomplexeHello News Desk,s (LPNCs) developed by Mirus enable superior transfection performance in a range of delivery applications Inve...
May 20, 2021 | News
Involving over 350 facilities, DHL distributed more than 200 million vaccine doses to over 120 countries to date From 2022 onward, a further 7-9 bi...
May 18, 2021 | News
Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups High immune response after a ...
May 17, 2021 | News
Positive regulatory advice received for development plan to provide POC in late-stage COVID-19 patients Additional opportunities in indications related ...
May 17, 2021 | News
Most Read
Bio Jobs
News